PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis. (Q54568696)

1 June 2018

title

PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis. (English)

1 reference

1 June 2018

1 reference

3

1 reference

1 June 2018

author name string

Arantza Fariña Sarasqueta

1

1 reference

1 June 2018

Eliane C M Zeestraten

2

1 reference

1 June 2018

Gesina van Lijnschoten

4

1 reference

1 June 2018

Ronald van Eijk

5

1 reference

1 June 2018

Jan Willem T Dekker

6

1 reference

1 June 2018

Peter J K Kuppen

7

1 reference

1 June 2018

Ines J Goossens-Beumer

8

1 reference

1 June 2018

Valery E P P Lemmens

9

1 reference

1 June 2018

Cornelis J H van de Velde

10

1 reference

1 June 2018

Harm J T Rutten

11

1 reference

1 June 2018

Hans Morreau

12

1 reference

1 June 2018

A J C van den Brule

13

1 reference

1 June 2018

publication date

10 August 2011

1 reference

1 June 2018

published in

Cellular Oncology

1 reference

1 June 2018

volume

34

1 reference

1 June 2018

page(s)

523-531

1 reference

1 June 2018

issue

6

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1007/s13402-011-0054-4

exact match

0 references

cites work

Current issues in adjuvant treatment of stage II colon cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Clinical implications of microsatellite instability in sporadic colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Class I PI3K in oncogenic cellular transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Cancer-specific mutations in PIK3CA are oncogenic in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Functional analysis of PIK3CA gene mutations in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Status of PI3K inhibition and biomarker development in cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Mutations of the PIK3CA gene in hereditary colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

PIK3CA mutations are not a major determinant of resistance to the epidermal growth factor receptor inhibitor cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Functional differences between two classes of oncogenic mutation in the PIK3CA gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Helical domain and kinase domain mutations in p110alpha of phosphatidylinositol 3-kinase induce gain of function by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Inhibitors of phosphatidylinositol-3-kinase in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-011-0054-4

Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas

21 January 2018

1 reference

12 December 2020

PIK3CA mutation is predictive of poor survival in patients with colorectal cancer

1 reference

12 December 2020

Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.

1 reference

12 December 2020

Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report

1 reference

12 December 2020

The essential role of phosphoinositide 3-kinases (PI3Ks) in regulating pro-inflammatory responses and the progression of cancer.

1 reference

12 December 2020

PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients

1 reference

12 December 2020

Chemotherapeutic implications in microsatellite unstable colorectal cancer

1 reference

12 December 2020

Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers

1 reference

12 December 2020

Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989-2006

1 reference

12 December 2020

Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients

1 reference

12 December 2020

10.1007/S13402-011-0054-4

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

21830111

1 reference

1 June 2018